MIST - Milestone Pharmaceuticals Inc

https://www.milestonepharma.com

Momentum: Bearish

Recent News

Why Is Milestone Pharmaceuticals Stock Plunging On Friday? - Milestone Pharmaceuticals ( NASDAQ:MIST )

FDA sets new target action date of Dec. 13, 2025, for Cardamyst nasal spray approval. Milestone expects $52.5 million in gross proceeds from public and pre-funded warrant offerings. Get daily-updated rankings across momentum, growth, value, trends, and quality to spot the strongest stocks in any ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.

52W High

$2.75

52W Low

$0.63

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.60

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.43

EV/Revenue (<3 favorable)

81.44

P/S (TTM) (<3 favorable)

77.32

P/B (<3 favorable)

4.96

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

3.37%

Institutions (25–75% balanced)

20.09%

Shares Outstanding

84,994,000

Float

53,457,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-0.84

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-7.80%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-1.00

Momentum

Bearish momentum

Value

0.0653

0.0494

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025